dr. kaufman discusses the use of eribulin in metastatic breast cancer
Published 11 years ago • 861 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:14
dr. kaufman on the side effect profiles of eribulin and capecitabine
-
2:42
eribulin as treatment for metastatic breast cancer
-
4:12
eribulin in recurrent metastatic er breast cancer
-
2:19
dr. twelves discusses eribulin for the treatment of breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
3:00
eribulin’s role in triple-negative breast cancer
-
5:25
eribulin in metastatic breast cancer
-
3:33
eribulin in metastatic tnbc: real-world data
-
1:10
dr. andrew d. seidman on targeted treatments in breast cancer
-
1:06
dr. vahdat on capecitabine and eribulin in advanced breast cancer
-
1:09
dr. vahdat discusses the side effects of halaven
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer
-
1:36
dr. chris twelves compares eribulin and capecitabine
-
0:49
andrew seidman, md: efficacy data supporting the use of eribulin mesylate
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
20:37
the role of chemotherapy in the treatment of metastatic breast cancer patients